Identity and percentage holding of significant shareholders
Substantial holdings | Shares held | % |
---|---|---|
Directors and related shareholders | ||
Ian Gilham | 614,295 | 0.66% |
David Budd | 293,710 | 0.32% |
Tom Lindsay | 262,717 | 0.28% |
Chris Yates | 67,554 | 0.07% |
Total Directors' holdings | 1,238,276 | 1.34% |
Total shares in issue | 92,549,946 | 100.00% |
Shareholder information
genedrive shares are quoted and traded on the AIM market of the London Stock Exchange.
Authorised Share Capital: No authorised maximum number of shares are required. There are no shares held in treasury and there are no restrictions on transfer.
Issued Share Capital: The total number of genedrive plc ordinary shares of 1.5p each in issue is 92,542,446.
Number of AIM securities not in public hands is 1,238,276 or 1.34%.
Text updated: 31/03/2023
Latest reports

31 March 2023
Interim Report and accounts 31 December 2022
Investor News
Wednesday February 03, 2021
Genedrive close to hitting the market with coronavirus tests
Friday May 19, 2023
Genedrive jumps 24% after UK regulatory thumbs up
Thursday March 30, 2023
Genedrive receives final approval from NICE for MT-RNR1 ID kit